Distinguished Medical and Public Policy
Leaders
Science in Donation & Transplant (SID&T), a leading
national public affairs and policy group dedicated to scientific
research and innovation in organ donation and transplantation
oversight and governance, today announced it has created a new
Advisory Board and appointed initial members. The SID&T
Advisory Board is intended to provide counsel and guidance to
advocacy of donation and transplantation performance measurement,
policy development, and messaging to ensure the public trust that
is essential to organ donation.
The advisory board members bring clinical transplantation,
transplant and donation ethics, governmental oversight, and public
policy experience to SID&T and include:
Matthew Cooper, MD
Chief of Transplantation, Director of Solid
Organ Transplant and a Professor of Surgery at the Medical College
of Wisconsin and Mark B. Adams Distinguished Professor of
Surgery.
Anthony Watkins, MD
Surgical Director of Kidney & Pancreas
Transplant Program and Associate Professor of Surgery at Tampa
General Hospital Transplant Institute
Brendan Parent, JD
Director of transplant ethics and policy
research, and assistant professor of bioethics in the division of
medical ethics and surgery at NYU Grossman School of Medicine
Anne Murphy, MBA FACHE
Consultant and former Chief Administrative
Officer, Department of Learning Health Sciences University of
Michigan Medical School, and Transplant Center Administrative
Director – University of Michigan Hospitals and Health Centers
J. Thomas Rosenthal, MD
Retired Chief Medical Officer, UCLA Medical
Center, Associate Vice Chancellor, David Geffen School of Medicine
at UCLA, Director of the Kidney Transplant Program at UCLA.
Herb Conaway, MD, JD
New Jersey Assemblyman, Chair Health
Committee; US Congressional Candidate, Captain, US Air Force
Physician, Director of Health, Burlington County.
Dr. Rosenthal, “It is now well understood,
based on abundant scientific evidence, that the methodology in the
2020 OPO rule is fatally flawed, and that CMS is going to have to
revise the rule. The whole OPO accreditation process needs to be
modernized in accordance with long-standing and well-established
principles of measurement for quality and accreditation and as
proposed in the National Academies of Science, Engineering and
Medicine landmark 2022 study Realizing the Promise of Equity in the
Organ Transplantation System.”
Dr. Conaway, veteran legislator, “The best
governing hears from all sides, is thoroughly vetted and follows
the science. We need to bring expertise and commonsense judgement
to produce the best policy.”
Anne Murphy, “The U.S. Organ Donation and
Transplantation system is renowned as the world's most advanced and
accomplished. We must insist that changes and improvements to this
system be driven from evidence-based practice and scientific study,
rather than various looming and, sometimes, competing forms of
self-interest. We owe this to the patients and families we serve,
whose lives and wellbeing hang in the balance.”
Dr. Watkins, “By fostering partnerships
across clinical, scientific, and policy domains, we can drive
necessary improvements that are both innovative and inclusive,
ensuring every patient has the chance for a life-saving
transplant.”
SID&T and its Advisory Board members are devoted to the
promotion of and reliance on vetted, peer-reviewed, and published
scientific research to continue the growth of the world-leading
U.S. donation and transplant system. SID&T provides education,
access to research, and expertise for policymakers, media, and the
public.
Policy makers in Congress and the Executive branch need to
assure all that patient outcomes and donor family gifts will be
guided by the best data and best practices. SID&T’s primary
goal is to ensure that the metrics and measures used to credential,
license, designate, and certify donation and transplant
organizations are grounded in science, are based upon sound
statistical and demographic analyses, and are protected from
political whim and private financial influence.
The donation and transplant community is increasingly concerned
over the impact of disinformation on the development of critical
public policies, governance, and regulation affecting organ
donation and transplantation. With the help of our highly qualified
Advisory Board, SID&T is expanding our outreach and voice to
provide evidence-based, scientifically sound information to
regulators, members of Congress and their staffs, media, transplant
professionals, patients and donor families.
Science in Donation &Transplant is a collective of public
policy, governmental, legislative, clinical, and public affairs
professionals, and its work can be found at: https://sidandt.org/,
https://www.instagram.com/scienceindonation,
https://twitter.com/scnceindonation.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241008546185/en/
John Samerjan jns@sidandt.org